110 related articles for article (PubMed ID: 12799191)
1. WT1 expression does not disrupt myogenic differentiation in C2C12 murine myoblasts or in human rhabdomyosarcoma.
Tiffin N; Williams RD; Robertson D; Hill S; Shipley J; Pritchard-Jones K
Exp Cell Res; 2003 Jul; 287(1):155-65. PubMed ID: 12799191
[TBL] [Abstract][Full Text] [Related]
2. Oncofetal expression of Wilms' tumor 1 (WT1) protein in human fetal, adult and neoplastic skeletal muscle tissues.
Magro G; Salvatorelli L; Puzzo L; Musumeci G; Bisceglia M; Parenti R
Acta Histochem; 2015; 117(4-5):492-504. PubMed ID: 25800978
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.
Skrzypek K; Kusienicka A; Szewczyk B; Adamus T; Lukasiewicz E; Miekus K; Majka M
Oncotarget; 2015 Oct; 6(31):31378-98. PubMed ID: 26384300
[TBL] [Abstract][Full Text] [Related]
4. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors.
Carpentieri DF; Nichols K; Chou PM; Matthews M; Pawel B; Huff D
Mod Pathol; 2002 Oct; 15(10):1080-6. PubMed ID: 12379755
[TBL] [Abstract][Full Text] [Related]
5. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
Liu LN; Dias P; Houghton PJ
Cell Growth Differ; 1998 Sep; 9(9):699-711. PubMed ID: 9751114
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel genes expressed during rhabdomyosarcoma differentiation using cDNA microarrays.
Carey KA; Segal D; Klein R; Sanigorski A; Walder K; Collier GR; Cameron-Smith D
Pathol Int; 2006 May; 56(5):246-55. PubMed ID: 16669873
[TBL] [Abstract][Full Text] [Related]
7. Role of the α2 subunit of AMP-activated protein kinase and its nuclear localization in mitochondria and energy metabolism-related gene expressions in C2C12 cells.
Okamoto S; Asgar NF; Yokota S; Saito K; Minokoshi Y
Metabolism; 2019 Jan; 90():52-68. PubMed ID: 30359677
[TBL] [Abstract][Full Text] [Related]
8. Myogenesis and rhabdomyosarcoma the Jekyll and Hyde of skeletal muscle.
Saab R; Spunt SL; Skapek SX
Curr Top Dev Biol; 2011; 94():197-234. PubMed ID: 21295688
[TBL] [Abstract][Full Text] [Related]
9. The Wilms' tumor suppressor Wt1 is associated with the differentiation of retinoblastoma cells.
Wagner N; Wagner KD; Schley G; Coupland SE; Heimann H; Grantyn R; Scholz H
Cell Growth Differ; 2002 Jul; 13(7):297-305. PubMed ID: 12133898
[TBL] [Abstract][Full Text] [Related]
10. A novel adipokine C1q/TNF-related protein 3 is expressed in developing skeletal muscle and controls myoblast proliferation and differentiation.
Otani M; Furukawa S; Wakisaka S; Maeda T
Mol Cell Biochem; 2015 Nov; 409(1-2):271-82. PubMed ID: 26272338
[TBL] [Abstract][Full Text] [Related]
11. RASSF4 is required for skeletal muscle differentiation.
Lin YT; Deel MD; Linardic CM
Cell Biol Int; 2020 Feb; 44(2):381-390. PubMed ID: 31508857
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma.
Wang W; Kumar P; Wang W; Epstein J; Helman L; Moore JV; Kumar S
Cancer Res; 1998 Oct; 58(19):4426-33. PubMed ID: 9766674
[TBL] [Abstract][Full Text] [Related]
13.
Kendall GC; Watson S; Xu L; LaVigne CA; Murchison W; Rakheja D; Skapek SX; Tirode F; Delattre O; Amatruda JF
Elife; 2018 Jun; 7():. PubMed ID: 29869612
[TBL] [Abstract][Full Text] [Related]
14. Delta-like 1 homolog (dlk1): a marker for rhabdomyosarcomas implicated in skeletal muscle regeneration.
Jørgensen LH; Sellathurai J; Davis EE; Thedchanamoorthy T; Al-Bader RW; Jensen CH; Schrøder HD
PLoS One; 2013; 8(4):e60692. PubMed ID: 23577150
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing of MEF2C pre-mRNA controls its activity in normal myogenesis and promotes tumorigenicity in rhabdomyosarcoma cells.
Zhang M; Zhu B; Davie J
J Biol Chem; 2015 Jan; 290(1):310-24. PubMed ID: 25404735
[TBL] [Abstract][Full Text] [Related]
16. Myogenic differentiation depends on the interplay of Grb2 and N-WASP.
Mitra P; Thanabalu T
Biochim Biophys Acta Mol Cell Res; 2017 Mar; 1864(3):487-497. PubMed ID: 27965114
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells and myoblast differentiation under HGF and IGF-1 stimulation for 3D skeletal muscle tissue engineering.
Witt R; Weigand A; Boos AM; Cai A; Dippold D; Boccaccini AR; Schubert DW; Hardt M; Lange C; Arkudas A; Horch RE; Beier JP
BMC Cell Biol; 2017 Feb; 18(1):15. PubMed ID: 28245809
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of mechanosensitive cation channels inhibits myogenic differentiation by suppressing the expression of myogenic regulatory factors and caspase-3 activity.
Wedhas N; Klamut HJ; Dogra C; Srivastava AK; Mohan S; Kumar A
FASEB J; 2005 Dec; 19(14):1986-97. PubMed ID: 16319142
[TBL] [Abstract][Full Text] [Related]
19. The brain expressed x-linked gene 1 (Bex1) regulates myoblast fusion.
Jiang C; Wang JH; Yue F; Kuang S
Dev Biol; 2016 Jan; 409(1):16-25. PubMed ID: 26586200
[TBL] [Abstract][Full Text] [Related]
20. Cadherin-11 is highly expressed in rhabdomyosarcomas and during differentiation of myoblasts in vitro.
Markus MA; Reichmuth C; Atkinson MJ; Reich U; Hoffmann I; Balling R; Anderer U; Höfler H
J Pathol; 1999 Jan; 187(2):164-72. PubMed ID: 10365091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
